News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Daily News Questions Raised About Study Linking mRNA Vaccines to Increased ACS Risk Todd Neale December 03, 2021
News Daily News No Uptick in CVD Events After COVID-19 Vaccination in Older Adults Michael O'Riordan November 29, 2021
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Conference News AHA 2021 Aspirin Fails to Prevent Onset of Dementia in Diabetic Patients: ASCEND Michael O'Riordan November 17, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AHA 2021 Avoiding AF Triggers Doesn’t Improve Quality of Life: I-STOP-AFib Michael O'Riordan November 14, 2021
News Conference News AHA 2021 Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown Yael L. Maxwell November 14, 2021
News Conference News AHA 2021 Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients Michael O'Riordan November 13, 2021
News Conference News AHA 2021 Village-Level Intervention Nets Big BP Control Gains in Rural China Todd Neale November 13, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Daily News CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes L.A. McKeown November 01, 2021